Revolution Medicines has made a major commitment toward discovering and developing small molecule inhibitors of PTPs.
Read more
We have a major commitment to developing bRo5 small molecule drug candidates for frontier targets like 4EBP1/mTORC1.
Our deep expertise in cancer biology and our drug discovery skills and methods combine to form our product engine directed to frontier cancer targets.
Partnering